42
A very interesting study showed that treatment with CART cells that target the urokinase plasminogen activator receptor (uPAR), which is associated with aging, improves exercise capacity in normal aging and improves metabolic dysfunction (for example, improving glucose resistance) in aged mice and in mice on a high-fat diet. Importantly, a single administration of these senolytic CART cells is sufficient to achieve long-term therapeutic and preventive results.